SynthesisBritish journal of clinical pharmacology2006

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin.

Eric Snoeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.